Karin Hardt
- Hepatology top 2%
- Hepatitis Viruses Studies and Epidemiology 6
- Epidemiology top 2%
- Hepatitis B Virus Studies 12
- Cervical Cancer and HPV Research 9
- Influenza Virus Research Studies 7
- Pneumonia and Respiratory Infections 6
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology 7
- Microbiology top 2%
- Bacterial Infections and Vaccines 8
- Health top 5%
-
- Viral Infections and Immunology Research 7
- Co-authors
- Dominique DescampsGary DubinBart SpiessensThomas VerstraetenPatricia IzurietaThomas BreuerPierre Van DammeMarie‐Pierre David
- Journals
- Vaccine (13 papers)Human Vaccines & Immunotherapeutics (5 papers)The Pediatric Infectious Disease Journal (3 papers)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Karin Hardt
44 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 98
- Hepatology 368
- Epidemiology 1.1k
- Infectious Diseases 545
- Microbiology 181
- Health 233
Countries citing papers authored by Karin Hardt
This map shows the geographic impact of Karin Hardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Hardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Hardt more than expected).
Fields of papers citing papers by Karin Hardt
This network shows the impact of papers produced by Karin Hardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Hardt. The network helps show where Karin Hardt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karin Hardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2019 | 10 | |
| 3 | 2016 | 87 | |
| 4 | 2014 | 27 | |
| 5 | 2014 | 48 | |
| 6 | 2013 | 50 | |
| 7 | 2012 | 24 | |
| 8 | 2012 | 12 | |
| 9 | 2012 | 23 | |
| 10 | 2011 | 156 | |
| 11 | 2011 | 20 | |
| 12 | 2009 | 6 | |
| 13 | 2008 | 5 | |
| 14 | Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant. | 2007 | 5 |
| 15 | 2007 | 192 | |
| 16 | 2007 | 35 | |
| 17 | 2005 | 23 | |
| 18 | 2005 | 9 | |
| 19 | 1999 | 9 | |
| 20 | Die Glucoseresorption in der Rattenniere: Mikropunktionsanalysen der tubulren Glucosekonzentration bei freiem Flu | 1968 | 12 |
About Karin Hardt
Karin Hardt is a scholar working on Microbiology, Hepatology and Epidemiology, having authored 44 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (12 papers), Cervical Cancer and HPV Research (9 papers), Bacterial Infections and Vaccines (8 papers), Viral gastroenteritis research and epidemiology (7 papers), Influenza Virus Research Studies (7 papers), Viral Infections and Immunology Research (7 papers), Pneumonia and Respiratory Infections (6 papers) and Hepatitis Viruses Studies and Epidemiology (6 papers). The work is most often cited by research in Hepatology (368 citations), Epidemiology (1.1k citations) and Infectious Diseases (545 citations). Karin Hardt has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Dominique Descamps, Gary Dubin, Bart Spiessens, Thomas Verstraeten, Patricia Izurieta, Thomas Breuer, Pierre Van Damme, Marie‐Pierre David, Toufik Zahaf and Koen Van Herck. Their work appears in journals such as Vaccine, Human Vaccines & Immunotherapeutics, The Pediatric Infectious Disease Journal, Journal of Adolescent Health and Human Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.